Skip to main content

Other

In Israel (as of Feb 2021) 84% of those ≥70 years and 10% for <50 years have received 2 doses of the COVID Vaccine; as such the need for mechanical ventilation in the elderly has declined 67% with the implementation of COVID vaccines. https://t.co/9Qnv72QYUS

Dr. John Cush @RheumNow( View Tweet )

Mar 01, 2021
My Experience as a COVID19 Vaccine Trial Participant https://t.co/ILfXLUL8IZ

Dr. John Cush @RheumNow( View Tweet )

Feb 28, 2021
We are three weeks out from RheumNow Live. Are you planning on attending? https://t.co/vJlU0Z3Q3x

Dr. John Cush @RheumNow( View Tweet )

Feb 26, 2021
RheumNow Podcast Available– Sweet Lies or Hard Truths Available for download on Soundcloud, and Apple and Android devices. https://t.co/undJYMoUOQ https://t.co/LzgvUUyoWs
Dr. John Cush @RheumNow( View Tweet )
Feb 26, 2021
How to reduce Zoom Burnout? - 4 tips from research: 1.Dont sit too close, and reduce monitor/image size 2. Avoid INFO overload 3. Move (think better when mobile) 4. Turn off Self view (avoid self evaluation) https://t.co/Xi5Ha76D0t

Dr. John Cush @RheumNow( View Tweet )

Feb 26, 2021
Medscape has published the 2021 Rheumatologist Lifestyle, Happiness & Burnout Report. Happy went down during COVID 79% to 49% 32% burnt out; 11% depressed 51% have workplace issues Half take 3-4 wks vacation https://t.co/g8UAHtiLIB

Dr. John Cush @RheumNow( View Tweet )

Feb 22, 2021
RheumNow Podcast: 2021 RWCS Review Drs. Jack Cush and Arthur Kavanaugh recap highlights from the 2021 Rheumatology Winter Clinical Symposium. https://t.co/iyYaO3NOBS

Dr. John Cush @RheumNow( View Tweet )

Feb 15, 2021
Dr. Shenoi reviews the history of Autoinflammatory Diseases -- improved with genetic testing (2007) and completion of the human genome project (2003) #RWCS2021 #RWCS @RWCSmtg @RheumNow https://t.co/0NRSbg2ZJs
Dr. Rachel Tate @uptoTate( View Tweet )
Feb 13, 2021
Hey one license for 28 states, working with telemedicine @RWCSmtg @alvinwellsmd https://t.co/crZqC9sPAp
Dr. John Cush @RheumNow( View Tweet )
Feb 13, 2021
PFAPA (aka Marshall syndrome) also occurs in adults @RWCSmtg https://t.co/52NVpKGCzP
Dr. John Cush @RheumNow( View Tweet )
Feb 13, 2021
Dr. Susan Shenoy @rwcs shows discovery of autoinflammatory diseases began w MEFV genes (FMF) in 1997, followed by genes for TRAPS and HIDS in 1999. @ https://t.co/sG4BlK1zhR
Dr. John Cush @RheumNow( View Tweet )
Feb 13, 2021
A serious shortage of pediatric rheumatologists in the USA, where we need at least 1 ped rheum per 400,000 population. @RWCSmtg https://t.co/o8XCkjUOaN
Dr. John Cush @RheumNow( View Tweet )
Feb 12, 2021
Dr George F Still, among the first to write about children with arthritis, pediatric Rheumatology, in 1898, with his description of 22 kids with arthritis. @RWCSmtg https://t.co/Y6DOzooFjZ
Dr. John Cush @RheumNow( View Tweet )
Feb 12, 2021
Congrats to ACR Task Force who published guidelines on RMD drug use w/ COVID vaccines. My views on their recs: 1. I agree, no change most DMARD, biologics 2. I disagree; I would NOT hold Orencia, I would NOT hold JAKi 3. I disagree: I would not hold MTX https://t.co/uSPfvJB8EC https://t.co/SznUJosmpo
Dr. John Cush @RheumNow( View Tweet )
Feb 10, 2021
IVIg in MIS-C Among children with multisystem inflammatory syndrome (MIS-C), treatment with IVIG and methylprednisolone vs IVIG alone was associated with a more favorable fever course. https://t.co/iCyJd3bbao https://t.co/edgVLpMP5a
Dr. John Cush @RheumNow( View Tweet )
Feb 10, 2021
QD Clinic - What Were You Thinking Pet Peeve Issues in Patient Care https://t.co/BpjXbsdWr5

Dr. John Cush @RheumNow( View Tweet )

Feb 05, 2021
Congratulations to Dr. Daniel Kastner for winning the 2021 Crafoord Prize in Polyarthritis, “for establishing the concept of autoinflammatory diseases.” The Royal Swedish Academy of Sciences and the Crafoord Foundation issue this award annually. https://t.co/yj218sGcwG

Dr. John Cush @RheumNow( View Tweet )

Feb 03, 2021
2016 Deloitte report on top 10 healthcare innovations (Spot on!): 1 Next gen sequencing 2 3-D printing 3 AI 4 Immunotherapy 5 Point of care diagnostics 6 virtual reality 7 social media for Pts 8 Biosensors/trackers 9 Telehealth 10 Convenient care https://t.co/yWaqzM9pFC

Dr. John Cush @RheumNow( View Tweet )

Jan 29, 2021
News: #COVID19 risk may be reduced with #biologics and #JAKinhibitors, but increased with #glucocorticoids, Italian researchers report in @ArthritisRes https://t.co/zIef2aNCns

Medicine Matters rheumatology @Rheum_Matters( View Tweet )

Jan 29, 2021
QD Clinic - Dadgummit, Where's Waldo's COVID Vaccine? My rant on the COVID vaccine unavailability, and what we can - and can't - tell patients. https://t.co/VKrDgvuXqt https://t.co/zuNe8lEaR4
Dr. John Cush @RheumNow( View Tweet )
Jan 28, 2021
Rheumatologists Rank 2nd in Physician Burnout The 2021 Medscape Survey on Physician burnout ranks rheumatology second, just behind Critical Care medicine. https://t.co/nIDqa5TCqG https://t.co/psem4wYIlN
Dr. John Cush @RheumNow( View Tweet )
Jan 27, 2021
QD Clinic Week Of 1.17.2021 Myalgias & Arthralgias, Smoking and RA, The Dastardly, nastardly facts of smoking and RA, Oivay the Elevated ESR https://t.co/hTQ46YZTzG

Dr. John Cush @RheumNow( View Tweet )

Jan 24, 2021

COVID Vaccine Q & A - Dr Kevin Winthrop Dr. Cush interviews Dr. Kevin Winthrop (OHSU) on the use and caveats to COVID-19 vaccination in patients with rheumatic disease and taking biologic and DMARD therapies https://t.co/EJL6hVLnrp https://t.co/XOHk9T04rx

Dr. John Cush @RheumNow( View Tweet )
Jan 22, 2021

NEJM: Early Combo Monoclonal Antibody Therapy in COVID-19

Jan 21, 2021

NEJM has published the interim analysis of the REGN-COV2 trial, wherein an antibody cocktail reduced viral loads with less clinical consequences. 



Recent data suggest that high viral loads are associated with greater risk for COVID-19 complications and death. A combination of two

Read Article

Combo Anti-Spike Protein Antibody for Mild to Moderate COVID-19

Jan 21, 2021

JAMA has published the BLAZE-1 study, showing significant SARS-CoV-2 viral load reduction at day 11 and less COVID-19 progression when combination anti-spike monoclonal antibody therapy (bamlanivimab and etesevimab) was given to mild to moderate, non-hospitalized COVID-19 patients.

Read Article
×